February 25, 2023

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – FATE

NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 22, 2023.

SO WHAT: If you purchased Fate securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Fate class action, go to https://rosenlegal.com/submit-form/?case_id=11392 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 22, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose, among other things, that: (1) the Janssen Collaboration Agreement was less sustainable than Fate had represented to investors; (2) accordingly, certain of the clinical programs, milestone payments, and royalty payments associated with the Janssen Collaboration Agreement could not be relied upon as future revenue sources; (3) as a result, Fate had overstated the impact of the Janssen Collaboration Agreement’s on Fate’s long-term clinical and commercial profitability; and (4) as a result, the Company’s public statements were materially false and misleading at all relevant times. When the truth emerged, the lawsuit claims that investors suffered damages.

To join the Fate class action, go to https://rosenlegal.com/submit-form/?case_id=11392 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm.

Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm’s attorneys are ranked and recognized by numerous independent and respected sources. Rosen Law Firm has secured hundreds of millions of dollars for investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40^th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8756654

February 25, 2023

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Bioventus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BVS

NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Bioventus Inc. (NASDAQ: BVS): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s February 11, 2021 initial public offering (the “IPO” or “Offering”); and/or (ii) between February 11, 2021 and November 21, 2022, both dates inclusive (the “Class Period”), of the important March 13, 2023 lead plaintiff deadline.

SO WHAT: If you purchased Bioventus securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Bioventus class action, go to https://rosenlegal.com/submit-form/?case_id=10065 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 13, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, the Offering Documents and defendants statements throughout the Class Period were false and/or misleading and/or failed to disclose that: (1) Bioventus suffered from significant liquidity issues; (2) the Company’s rebate practices were unsustainable; (3) accordingly, defendants overstated the Company’s business and financial prospects; (4) Bioventus maintained deficient disclosure controls and procedures and internal control over financial reporting with respect to the timely recognition of quarterly rebates; (5) all the foregoing increased the risk that the Company would be forced to recognize a significant non-cash impairment charge, could not timely file one or more of its financial reports, would have to amend one or more of its financial statements, and could not meet its financial obligations as they came due; and (6) as a result, the Offering Documents were materially false and/or misleading and failed to state information required to be stated therein. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Bioventus class action, go to https://rosenlegal.com/submit-form/?case_id=10065 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com

GlobeNewswire Distribution ID 8756623

February 25, 2023

BLRX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 6 Deadline in Securities Class Action Filed by the Firm – BLRX

NEW YORK, Feb. 24, 2023 (GLOBE NEWSWIRE) —

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of BioLineRx Ltd. (NASDAQ: BLRX) between February 23, 2021 and September 19, 2022, both dates inclusive (the “Class Period”), of the important March 6, 2023 lead plaintiff deadline.

SO WHAT: If you purchased BioLine securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the BioLine class action, go to https://rosenlegal.com/submit-form/?case_id=8781 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 6, 2023. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose, among other things, that: (1) the Company was not well financed to develop Motixafortide while at the same time advancing other pipeline programs; (2) BioLine would require a loan from Kreos Capital VII Aggregator SCSP in an aggregate principal amount of up to $40 million and then also would require a $15M securities offering to facilitate the commercial launch of Motixafortide; and (3) as a result of the foregoing, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the truth emerged, the lawsuit claims that investors suffered damages.

To join the BioLine class action, go to https://rosenlegal.com/submit-form/?case_id=8781 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

——————————–

Contact Information:

GlobeNewswire Distribution ID 8756621

February 25, 2023

RHF Secretary-General, Syrian Local Administration Minister discuss distribution of Bahraini aid

Secretary-General of the Royal Humanitarian Foundation (RHF), CEO of the National Committee for Supporting Earthquake Victims in Syria and Türkiye, Dr. Mustafa Al-Sayed, held a meeting with Syrian Minister of Local Administration and Environment, Chairman of the Higher Committee for Relief, Hussein Makhlouf.

The meeting focused on the relief aid shipment delivered by Bahrain to Syria, in line with the directives of His Majesty King Hamad bin Isa Al Khalifa, within the framework of the humanitarian response to face the repercussions and damages caused by the earthquake that struck Syria recently.

Dr. Al-Sayed asserted that based on HM the King’s directives and the support of the government, led by His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, the RHF, under the leadership of HM the King’s Representative for Humanitarian Work and Youth Affairs, His Highness Shaikh Nasser bin Hamad Al Khalifa, seeks to provide the necessary assistance to quake-affected brotherly Syrian citizens.

He indicated that the visit aims to collect first-hand information about the damages caused by the quake, and determine necessary needs to discuss the possibility of providing them in various fields, especially in the relief and humanitarian ones.

He added that work is currently underway with the relevant UN Agencies and the Syrian Arab Red Crescent to support earthquake victims in the quake-affected regions of Syria and to restore some of the infrastructure impacted by the earthquake in cooperation with UN agencies.

Minister Hussein Makhlouf expressed the Syrian people’s pride in the deep-rooted relations between the two countries, stressing the importance of the stances of Bahrain’s leadership, government and people in strengthening ties between the two brotherly peoples.

He affirmed that all necessary facilities have been provided to ensure the delivery of Bahraini aid to the affected governorates and its distributions under the supervision of international relief organisations.

Source: Bahrain News Agency

February 25, 2023

HH Shaikh Nasser bin Hamad Al Khalifa wins World Endurance Championship

His Majesty the King’s Representative for Humanitarian Work and Youth Affairs, Royal Endurance Team Captain HH Shaikh Nasser bin Hamad Al Khalifa has clinched the World Endurance Championship.

HH Shaikh Nasser bin Hamad outclassed other contenders from the United Arab Emirates, Uruguay and Spain to win the race and clinch the trophy, clocking 7 hours, 36 minutes and 39 seconds.

HM King Hamad bin Isa Al Khalifa followed up the 160-kilometre race which was held at Boudheeb Global Village in the United Arab Emirates. A total of 126 contenders representing 36 countries were in the fray vying for the trophy.

HH Shaikh Nasser bin Hamad dedicated the victory to HM the King, praising royal support to sports in the Kingdom of Bahrain, particularly endurance sports. He noted the string of landmark sports achievements in the prosperous era of HM the King,

HH Shaikh Nasser bin Hamad also expressed sincere thanks and gratitude to His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister for his continued support.

He hailed the success of the United Arab Emirates in hosting the world endurance championship, praising the outstanding organization which reflects the UAE’s ability to hold major sporting events.

Supreme Council for Youth and Sports (SCYS) First Deputy Chairman, General Sports Authority (GSA) Chairman and Bahrain Olympic Committee (BOC) President HH Shaikh Khalid bin Hamad Al Khalifa followed up the race and congratulated HH Shaikh Nasser on the victory.

Source: Bahrain News Agency

February 25, 2023

HM King congratulates HH Shaikh Nasser on endurance trophy

His Majesty King Hamad bin Isa Al Khalifa today attended the World Endurance Championship which was held at the Boudheeb Global Endurance Ville in Abu Dhabi, the United Arab Emirates.

The 160-kilometre race was held under the patronage of UAE Deputy Prime Minister and Presidency Court Minister His Highness Shaikh Mansour bin Zayed Al Nahyan.

HM the King’s Representative for Humanitarian Work and Youth Affairs HH Shaikh Nasser bin Hamad Al Khalifa led the Royal Endurance Team to the championship which was organized byu the International Endurance Federation.

HM the King watched the World Endurance Championship which saw the participation of jockeys from Bahrain alongside 126 other contenders representing 36 countries.

HM the King hailed the strength of historic relations binding the Kingdom of Bahrain and the United Arab Emirates, praising the outstanding organization which reflects the UAE’s world standing and reputation in hosting major sporting events.

HM the King congratulated HH Shaikh Nasser bin Hamad Al Khalifa on winning the race and claiming the trophy, expressing pride in the global historic achievements which further enriches HH Shaikh Nasser’s record of victories.

HM the King praised HH Shaikh Nasser’s outstanding performance, which enabled him to win the championship, reflecting the standing of the endurance sport in the Kingdom of Bahrain.

HM the King noted that the endurance sport is deeply-rooted in the history and heritage of the region, stressing keenness to further support and develop the sport.

Source: Bahrain News Agency